e 64 has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, J; Odero-Marah, V; Payne, CK; Peyton, SR; Platt, MO; Stewart, FAA; Walton, C; Watson, V; Wilder, CL | 1 |
| Brábek, J; Folk, P; Mierke, CT; Panková, D; Rösel, D; Tolde, O; Vesely, P | 1 |
2 other study(ies) available for e 64 and Breast Cancer
| Article | Year |
|---|---|
Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
Topics: Breast Neoplasms; Cathepsin L; Cathepsins; Cell Line, Tumor; Cystatin C; Cytoplasm; Feedback, Physiological; Humans; Leucine; Protease Inhibitors; Protein Transport; Up-Regulation | 2016 |
Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP.
Topics: Actins; Aprotinin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytoskeleton; Dipeptides; Disease Progression; Female; Gelatin; Humans; Leucine; Marine Toxins; Matrix Metalloproteinase 14; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases, Secreted; Neoplasm Invasiveness; Neoplastic Stem Cells; Protease Inhibitors; Pseudopodia; Up-Regulation | 2010 |